Vivek Yadav

Statistics

Publications

Citations

121

H-Index

Active since

2022

Affiliations

National Institute of Pharmaceutical Education and Research(Current)

National Institute of Pharmaceutical Education and Research

Vivek Yadav is an author at National Institute of Pharmaceutical Education and Research specializing in nanoparticle formulations, nanoparticle drug delivery, and drug delivery.

ORCID

Publications per year

2022–2024

Publications

Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer

Dasharath Chaudhari, Kaushik Kuche, Vivek Yadav et al. · Drug Delivery and Translational Research · 2022 · 41 citations

Pharmacy, Oncology, Pharmacology +14

Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin

Kaushik Kuche, Vivek Yadav, M. Dharshini et al. · International Journal of Biological Macromolecules · 2023 · 28 citations

Pharmacy, Oncology, Pharmacology +14

Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy

Kaushik Kuche, Vivek Yadav, Meet Patel et al. · Biomaterials Advances · 2023 · 20 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Hyaluronic acid functionalized liposomes for co-delivery of paclitaxel and ursolic acid for enhanced efficacy against triple negative breast cancer

Reena Sharma, Vivek Yadav, Oly Katari et al. · Journal of Drug Delivery Science and Technology · 2024 · 19 citations

Pharmacy, Oncology, Pharmaceutics +17

Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety Assessment

Kaushik Kuche, Vivek Yadav, Meet Patel et al. · AAPS PharmSciTech · 2023 · 13 citations

Medicine, Oncology, Pharmacology +8

1–5 of 5